Dyne Therapeutics, Inc. (DYN)

Dyne Therapeutics, Inc. (DYN) is a healthcare company (biotechnology) based in the United States. The share price is $16.23, down 2.81% on the day, which values the company at $3.04B. Price as of 17 Nov 2026, 17:30 UTC, from Yahoo Finance.

Key facts

Share price
$16.23−2.81% today
Market value
$3.04B
200-week average
$18.7413% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Dyne Therapeutics, Inc. in more detail

DYN trades at -4.6× next year's expected earnings. It sits 13% below its 200-week average of $18.74.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

2 of the superinvestors tracked here hold DYN, including Louis Bacon (0.2% of the portfolio), Julian and Felix Baker (0.1% of the portfolio).

Superinvestors holding DYN

2 of the investors tracked here report a position in their latest 13F filing.

Dyne Therapeutics, Inc. (DYN): questions and answers

What is Dyne Therapeutics, Inc.'s market cap?

Dyne Therapeutics, Inc. is valued at $3.04B at a share price of $16.23.

Is DYN above its 200-week moving average?

No. DYN is 13.4% below its 200-week average of $18.74. Long-term investors watch that line because strong companies rarely trade below it for long.

Does DYN pay a dividend?

Dyne Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own DYN?

In their latest quarterly filings, Louis Bacon (0.2% of the portfolio), Julian and Felix Baker (0.1% of the portfolio) hold DYN. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Dyne Therapeutics, Inc. (DYN) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/DYN

Underlying data: Yahoo Finance; company filings with the SEC.